TP53 and neutropenia: Other important factors, including patient demographics and general disease characteristics such as the presence of a TP53, DNMT3A, RUNX1, ASXL1, DDX41 mutation, grade III/IV neutropenia at baseline, or number of prior therapies were not found to be related to the probability of marrow remission in the logistic regression analyses.